László Lorenzovici

14.2k total citations
22 papers, 151 citations indexed

About

László Lorenzovici is a scholar working on Economics and Econometrics, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, László Lorenzovici has authored 22 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 4 papers in Immunology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in László Lorenzovici's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (6 papers) and Biosimilars and Bioanalytical Methods (4 papers). László Lorenzovici is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (6 papers) and Biosimilars and Bioanalytical Methods (4 papers). László Lorenzovici collaborates with scholars based in Romania, Hungary and Netherlands. László Lorenzovici's co-authors include Marcell Csanádi, Zoltán Kaló, Tomáš Tesař, András Inotai, Andrea Székely, Guenka Petrova, Tomasz Bochenek, Péter Gaál, Antal Zemplényi and Leoš Fuksa and has published in prestigious journals such as SHILAP Revista de lepidopterología, BioMed Research International and Frontiers in Pharmacology.

In The Last Decade

László Lorenzovici

18 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Lorenzovici Romania 9 68 38 23 14 14 22 151
Ariunaa Togtokh Mongolia 7 15 0.2× 25 0.7× 11 0.5× 27 1.9× 11 0.8× 7 251
Nicole Gri Italy 6 33 0.5× 6 0.2× 45 2.0× 6 0.4× 11 0.8× 9 221
V. V. Оmelyanovskiy Russia 7 53 0.8× 25 0.7× 18 0.8× 35 2.5× 19 1.4× 70 205
Ewa Stawowczyk Poland 10 136 2.0× 53 1.4× 27 1.2× 11 0.8× 44 3.1× 23 322
Shiwei Gong China 8 113 1.7× 16 0.4× 46 2.0× 5 0.4× 26 1.9× 17 256
Eun Kyong Shin United States 7 8 0.1× 17 0.4× 30 1.3× 6 0.4× 7 0.5× 25 159
Astrid James South Africa 8 28 0.4× 6 0.2× 29 1.3× 10 0.7× 8 0.6× 20 218
Juan Criniti Argentina 7 11 0.2× 17 0.4× 24 1.0× 10 0.7× 24 1.7× 13 151
Kiu Tay-Teo Switzerland 5 127 1.9× 29 0.8× 13 0.6× 8 0.6× 12 0.9× 8 307
Abrar-Ahmad Zulfiqar France 6 22 0.3× 11 0.3× 20 0.9× 9 0.6× 5 0.4× 27 108

Countries citing papers authored by László Lorenzovici

Since Specialization
Citations

This map shows the geographic impact of László Lorenzovici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Lorenzovici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Lorenzovici more than expected).

Fields of papers citing papers by László Lorenzovici

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Lorenzovici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Lorenzovici. The network helps show where László Lorenzovici may publish in the future.

Co-authorship network of co-authors of László Lorenzovici

This figure shows the co-authorship network connecting the top 25 collaborators of László Lorenzovici. A scholar is included among the top collaborators of László Lorenzovici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Lorenzovici. László Lorenzovici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lorenzovici, László, L. Daina, Dimitrie Siriopol, et al.. (2025). Epidemiology and hospitalization costs of chronic kidney disease in Romania. Health Economics Review. 15(1). 38–38.
2.
Lorenzovici, László, Zoltán Kaló, Violeta Briciu, et al.. (2025). Extended Analysis of the Hospitalization Cost and Economic Burden of COVID-19 in Romania. Healthcare. 13(9). 982–982.
3.
4.
Lorenzovici, László, Andrea Ildikó Gáspárik, Carsten Utoft Niemann, et al.. (2023). Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia. BioDrugs. 37(2). 219–233. 3 indexed citations
5.
Vesa, Ștefan Cristian, László Lorenzovici, Iulia-Ioana Stănescu-Spînu, et al.. (2023). A Potential Indicator for Assessing Patient Blood Management Standard Implementation. Healthcare. 11(16). 2233–2233. 3 indexed citations
6.
Németh, Bertalan, Maria Kamusheva, Antal Zemplényi, et al.. (2023). Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making. Journal of Comparative Effectiveness Research. 12(4). e220157–e220157. 2 indexed citations
7.
Zemplényi, Antal, Konstantin Tachkov, Bertalan Németh, et al.. (2023). Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment. Frontiers in Public Health. 11. 1088121–1088121. 20 indexed citations
8.
Gáspárik, Andrea Ildikó, et al.. (2023). Predictors of mortality for patients with hip fracture: a study of the nationwide 1-year records of 24,950 fractures in Romania. Archives of Osteoporosis. 18(1). 69–69. 3 indexed citations
9.
Lorenzovici, László, et al.. (2022). Burden of Chronic Heart Failure in Romania. Healthcare. 10(1). 107–107. 10 indexed citations
10.
Csanádi, Marcell, Zoltán Kaló, Maureen Rutten‐van Mölken, et al.. (2022). Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries. Health Policy. 126(11). 1173–1179. 12 indexed citations
11.
Lorenzovici, László, et al.. (2022). Jó ötlet-e a paraszolvencia kriminalizálása?. Orvosi Hetilap. 163(42). 1670–1681.
12.
Kovács, Sándor, Maciej Niewada, Mirjana Huić, et al.. (2021). Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges. Frontiers in Public Health. 8. 612410–612410. 12 indexed citations
13.
Inotai, András, D Tomek, Maciej Niewada, et al.. (2020). Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries. Frontiers in Pharmacology. 11. 845–845. 7 indexed citations
14.
Lorenzovici, László, Andrea Székely, Marcell Csanádi, & Péter Gaál. (2020). Cost Assessment of Inpatient Care Episodes of Stroke in Romania. Frontiers in Public Health. 8. 605919–605919. 11 indexed citations
15.
16.
Csanádi, Marcell, Zoltán Kaló, Leoš Fuksa, et al.. (2018). The implications of external price referencing on pharmaceutical list prices in Europe. Health Policy and Technology. 7(3). 243–250. 15 indexed citations
17.
Inotai, András, Marcell Csanádi, Guenka Petrova, et al.. (2018). Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. BioMed Research International. 2018. 1–9. 22 indexed citations
18.
Inotai, András, Marcell Csanádi, Dinko Vitezić, et al.. (2017). Policy Practices to Maximise Social Benefit from Biosimilars. Journal of Bioequivalence & Bioavailability. 9(4). 14 indexed citations
19.
Csanádi, Marcell, Guenka Petrova, Tomasz Bochenek, et al.. (2016). Mapping of The Biosimilar Drug Policy in 10 Central Eastern European Countries. Value in Health. 19(7). A504–A505. 2 indexed citations
20.
Lorenzovici, László, et al.. (2014). Economic Evaluation of Ulipristal Acetate for the Treatment of Patients With Moderate and Severe Symptoms of Uterine Fibroids in Romania. Value in Health. 17(7). A510–A510. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ariunaa Togtokh Breakdown of academic impact, for papers by Nicole Gri Breakdown of academic impact, for papers by V. V. Оmelyanovskiy Breakdown of academic impact, for papers by Ewa Stawowczyk Breakdown of academic impact, for papers by Shiwei Gong Breakdown of academic impact, for papers by Eun Kyong Shin Breakdown of academic impact, for papers by Astrid James Breakdown of academic impact, for papers by Juan Criniti Breakdown of academic impact, for papers by Kiu Tay-Teo Breakdown of academic impact, for papers by Abrar-Ahmad Zulfiqar
Rankless by CCL
2026